Literature DB >> 31582893

Juvenile Granulosa Cell Tumor with Elevated Peripheral Interleukin-6 Level Shows Prolonged Fever and Delayed Puberty.

Keisuke Okuno1, Naohiro Yoneda2, Rei Nishimura1, Hitoshi Sano1, Jun-Ichi Ueyama2, Hiroaki Komatsu3, Tasuku Harada4, Michiko Matsushita5, Satoshi Kuwamoto5, Yasushi Horie5, Susumu Kanzaki1.   

Abstract

Juvenile granulosa cell tumor (JGCT), classified as a sex cord-stromal tumor, is a rare neoplasm. This is an instructive case report of JGCT accompanied by augmented interleukin (IL)-6 secretion. A 13-year-old girl with prolonged fever and delayed puberty was diagnosed with JGCT of the left ovary based on an imaging study and pathological investigation. Although it was not clear whether IL-6 was secreted from the tumor cells, her serum level of IL-6 was very high. After tumorectomy, the patient's symptoms immediately disappeared, her IL-6 level decreased, and she entered puberty. Therefore, augmented IL-6 secretion production induced by tumors should be considered a potential cause of prolonged fever and/or delayed puberty. ©2019 Tottori University Medical Press.

Entities:  

Keywords:  delayed puberty; interleukin-6; juvenile granulosa cell tumor; prolonged fever

Year:  2019        PMID: 31582893      PMCID: PMC6739248          DOI: 10.33160/yam.2019.09.004

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.641


  14 in total

1.  Ovarian juvenile granulosa cell tumour in childhood: uncommon gynecological malignancy.

Authors:  Dhiraj B Nikumbh; Kishor H Suryawanshi; Anjali M Chitale; Poonam Pagare; Akshay Surana
Journal:  J Clin Diagn Res       Date:  2014-10-20

Review 2.  Interleukin-6 as an emerging regulator of renal cell cancer.

Authors:  Katarzyna Kamińska; Anna M Czarnecka; Bernard Escudier; Fei Lian; Cezary Szczylik
Journal:  Urol Oncol       Date:  2015-08-18       Impact factor: 3.498

3.  Sex cord stromal tumors of the ovary in children: a clinicopathological report from the Italian TREP project.

Authors:  Giovanni Cecchetto; Andrea Ferrari; Gabriella Bernini; Rita Alaggio; Paola Collini; Calogero Virgone; Monica Terenziani; Patrizia Dall'igna; Raffaele Cozza; Massimo Conte; Gianni Bisogno
Journal:  Pediatr Blood Cancer       Date:  2010-12-15       Impact factor: 3.167

4.  Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas.

Authors:  Yasuo Adachi; Chieko Aoki; Naoko Yoshio-Hoshino; Koichi Takayama; David T Curiel; Norihiro Nishimoto
Journal:  Int J Cancer       Date:  2006-09-15       Impact factor: 7.396

5.  Systemic inflammatory syndrome and hepatic inflammatory cell infiltration caused by an interleukin-6 producing pheochromocytoma.

Authors:  Jeong Min Kang; Woo Je Lee; Won Bae Kim; Tae Yong Kim; Jung-Min Koh; Suck Joon Hong; Jooryung Huh; Jae Y Ro; Hyun Sook Chi; Min Seon Kim
Journal:  Endocr J       Date:  2005-04       Impact factor: 2.349

Review 6.  Impact of disease and treatments on growth and puberty of pediatric patients with inflammatory bowel disease.

Authors:  Jessica Ezri; Pedro Marques-Vidal; Andreas Nydegger
Journal:  Digestion       Date:  2012-06-08       Impact factor: 3.216

7.  Interleukin-6 production in primary histoculture by normal human kidney and renal tumor tissues.

Authors:  S G Chang; S J Lee; S J Lee; J I Kimi; J C Jung; J H Kim; R M Hoffman
Journal:  Anticancer Res       Date:  1997 Jan-Feb       Impact factor: 2.480

Review 8.  Clinical review of adult granulosa cell tumors of the ovary.

Authors:  R Segal; A D DePetrillo; G Thomas
Journal:  Gynecol Oncol       Date:  1995-03       Impact factor: 5.482

9.  A patient with malignant paraganglioma that simultaneously produces adrenocorticotropic hormone and interleukin-6.

Authors:  M Omura; T Sato; R Cho; T Iizuka; T Fujiwara; K Okamoto; Y Tashiro; S Chiba; T Nishikawa
Journal:  Cancer       Date:  1994-09-01       Impact factor: 6.860

10.  IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer.

Authors:  Miao-Fen Chen; Paul-Yang Lin; Ching-Fang Wu; Wen-Cheng Chen; Chun-Te Wu
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.